WBP1L regulates hematopoietic stem cell function and T cell development.

Area of Science:

• Hematology
• Immunology
• Molecular Biology

Background:

• WW domain binding protein 1-like (WBP1L), also known as outcome predictor of acute leukemia 1 (OPAL1), is a transmembrane adaptor protein.
• WBP1L expression correlates with ETV6-RUNX1 translocation and favorable prognosis in childhood leukemia.
• Previous studies identified WBP1L as a regulator of CXCR4 signaling and hematopoiesis.

Purpose of the Study:

• To investigate the role of WBP1L in regulating hematopoiesis and immune cell populations.
• To determine the effects of WBP1L deficiency on hematopoietic stem cells (HSCs) and progenitor cells.
• To analyze the impact of WBP1L on thymic development and leukocyte homeostasis.

Main Methods:

• Germline deletion of Wbp1l in mice.
• Analysis of hematopoietic stem cell and progenitor cell populations.
• Flow cytometry to assess thymocyte and peripheral blood cell subsets.
• Hematopoietic stem and progenitor cell transplantation experiments.

Main Results:

• Wbp1l germline deletion results in dysregulated hematopoiesis at the HSC and early progenitor levels.
• WBP1L-deficient mice exhibit significantly enlarged thymi with increased thymocyte numbers across all subsets.
• Increased generation of multipotent progenitors 4 (MPP4) in bone marrow and elevated leukocyte counts in blood were observed.
• WBP1L regulates HSC functionality and leukocyte progenitor proliferation, leading to enhanced engraftment of WBP1L-deficient cells post-transplantation.

Conclusions:

• WBP1L is a critical regulator of hematopoietic stem and progenitor cell function.
• WBP1L controls leukocyte numbers in both steady-state conditions and after bone marrow transplantation.
• Dysregulation of WBP1L impacts thymic development and peripheral blood cell homeostasis.